Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy for trans individuals is effective and generally safe in the short term.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

The document concludes that more inclusive research involving the transgender community is needed, especially on the neovaginal microbiome of trans women.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

The transgender community in India has specific skin care needs and struggles to access dermatological services due to discrimination and financial issues.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Surgeons must understand the full care process for gender confirmation surgery to help transgender individuals effectively.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Collecting sexual orientation and gender identity data in dermatology can lead to better, more sensitive care for sexual and gender minority patients.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Addressing underrepresentation in Parkinson's research is crucial for better treatments and understanding.

Air Vice-Marshal Sir Ralph Jackson significantly advanced dialysis technology in the UK.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

Recognize and treat hair loss conditions that mimic androgenetic alopecia by identifying warning signs and using proper tools.

Hair loss improved after removing pituitary tumor.

The critique suggests that Wilton's work unintentionally supports the very stereotypes it aims to question and calls for a broader, more inclusive approach to understanding gender.

A woman with PCOS successfully overcame secondary infertility and became pregnant with triplets after treatment.

Men and women have different hairline restoration needs, with natural design being more complex for women, and hairline changes being important for transgender individuals' transitions.

A woman had a skin reaction from a cough suppressant, dextromethorphan, which is a new cause of fixed-drug eruption.

A woman experienced temporary hair loss after taking albendazole, which resolved on its own within 3 months.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

A woman's hair loss was linked to a rare hormone-secreting ovarian tumor, treated with surgery and hair loss medication.

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

A woman's liver was damaged by taking the herbal supplement Shou-Wu-Pian, but it got better after she stopped using it.

A woman regrew her hair significantly using a corticosteroid cream with a plastic cover.

A woman developed male traits from accidental contact with her husband's testosterone gel.

A woman's liver problems improved after she stopped taking spironolactone.